Though Strict, CMS Aduhelm Policy May Create Pressure For Wider Coverage

By John Wilkerson, Gabrielle Wanneh / January 11, 2022 at 9:50 PM

The proposed Medicare national coverage policy for Aduhelm, and other prospective monoclonal antibodies for Alzheimer’s, is stricter than most that have come before it.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.